News

Oct. 08. 2019

Upsher-Smith Launches Tosymra^™ (sumatriptan) Nasal Spray for the Acute Treatment of Migraine in Adults

Sep. 06. 2019

Upsher-Smith Launches Morphine Sulfate Tablets

Aug. 28. 2019

MHLW Approves Additional Indications for CANDESARTAN Tablets and OD Tablets2

Aug. 15. 2019

Sawai Receives Approvals for Two Generic Drugs with Five Strengths

Aug. 06. 2019

Sawai Reports First Quarter FY2019 Financial Results

Jul. 23. 2019

Sawai Selected for FTSE4Good and FTSE Blossom Japan Indexes

Jul. 22. 2019

Upsher-Smith Laboratories Completes Acquisition of Two Treatments for Acute Migraine in Adults

Jun. 21. 2019

Osteoporosis drug "Minodronic Acid Tablets 50 mg [SAWAI]" wins "World Star Awards" in a prestigious packaging contest.

Jun. 18. 2019

MHLW Approves Additional Indications for METHOTREXATE Capsules

Jun. 14. 2019

Upsher-Smith Laboratories Enters Into Agreement to Acquire Tosymra^™ and Zembrace^® Symtouch^®

Jun. 13. 2019

Sawai Launches Three Generic Drugs with Seven Strengths

Jun. 05. 2019

MHLW Approves Additional Indication for LINEZOLID Injection and Tablets

May. 14. 2019

Sawai Reports FY2018 Financial Results

Mar. 28. 2019

Upsher-Smith Launches Generic Version of Prozac^® (Fluoxetine) Tablets

Mar. 27. 2019

MHLW Approves New Indication for DONEPEZIL Tablets, OD Tablets and Fine Granules

Mar. 06. 2019

MHLW Approves New Indication for ARIPIPRAZOLE Tablets and Oral Solution

Feb. 20. 2019

Upsher-Smith Laboratories, LLC celebrates its 100-year anniversary.

Feb. 15. 2019

Sawai Receives Approvals for Three Generic Drugs with Six Strengths

Feb. 14. 2019

Sawai Reports Third Quarter FY2018 Financial Results

Feb. 13. 2019

An interview with Mitsuo Sawai (President of Sawai Pharmaceutical Co., Ltd.) was published in 2019 Japan Business Report in the South China Morning Post.

Jan. 09. 2019

MHLW Approves New Indication for ARGATROBAN Injection

Dec. 13. 2018

Sawai Launches Six Generic Drugs with 14 Strengths

Dec. 05. 2018

MHLW Approves New Indication for RISEDRONATE Tablets and DOBUTAMINE I.V. Infusion

Nov. 21. 2018

MHLW Approves New Indication for LEVOFOLINATE I.V. Infusion